Author: et

GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

ANKARA, Turkey, Dec 2, 2025 – (ACN Newswire via SeaPRwire.com) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical company, has announced new positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class, novel orally

More